How likely are you to develop osteonecrosis of the jaw? Quality of Life 27. 06. 2025 Antiresorptive drugs help with osteoporosis and reduce bone complications in cancer patients, but they may cause osteonecrosis of the jaw (ONJ).Are you in the high-risk group? Tags: quality of life
Medication-Related Osteonecrosis of the Jaw (MRONJ): From Theory to Practice – Advanced Training Webinar Events, Seminars, & Publications 28. 01. 2026 The Next Step in Managing Patients on Antiresorptive MedicationsOn January 16, 180 dentists attended our first webinar on MRONJ and risk assessment.The response was immediate:“The STEPS and their eval...[Read more]
The 3-Step Safety System for Medication-Related Osteonecrosis of the Jaw (MRONJ) Events, Seminars, & Publications 07. 01. 2026 How to confidently treat patients receiving antiresorptive medicationsConnect with:Internationally Awarded Professor Ourania Nicolatou-Galitis,Member of the European Expert Panel on Osteonecrosis(Medi...[Read more]
Medication-Related Osteonecrosis of the Jaw in Cancer Therapy Events, Seminars, & Publications 13. 02. 2026 On April 2, mycancer invites you to another online seminar focusing on one of the most critical issues in modern Oncology:WEBINAR“Medication-Related Osteonecrosis of the Jaw in Cancer Therapy”Teaching...[Read more]
